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a  b  s  t  r  a  c  t
Waiting  times  for elective  treatments  are  a key  health-policy  concern  in several  OECD
countries.  This study  describes  common  measures  of  waiting  times  from  administrative
data  across  OECD  countries.  It focuses  on  common  elective  procedures,  such  as hip  and  knee
replacement,  and  cataract  surgery,  where  waiting  times  are  notoriously  long.  It  provides
comparative  data  on  waiting  times  across  12 OECD  countries  and  presents  trends  in waiting
times  over  the  last  decade.  Waiting  times  appear  to  be low  in the  Netherlands  and Denmark.
In  the last  decade  the United  Kingdom  (in  particular  England),  Finland  and  the  Netherlands
have  witnessed  large  reductions  in waiting  times  which  can be  attributed  to  a range  of
policy initiatives,  including  higher  spending,  waiting-times  target  schemes  and  incentive
mechanisms,  which  reward  higher  levels  of  activity.  The  negative  trend  in  these  countries
has, however,  halted  or  reversed  in recent  years.  The  analysis  also emphasizes  systematic
differences  across  different  waiting-time  measures,  in  particular  between  the distribution
of waiting  times  of patients  treated  versus  that of  patients  on  the list.  Mean  waiting  times  are
systematically  higher  than  median  waiting  times  and  the difference  can be quantitatively
large.
©  2014  Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license1. IntroductionWaiting times for elective procedures are a major health
policy concern in many OECD countries. Policymakers face
considerable challenges in reducing them. Initiatives are
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regularly introduced to tackle excessive waiting times with
varying success [1].
This study aims to provide comparative evidence of
waiting times across OECD countries and explores trends
and health policies aimed at reducing waiting times in
the last decade. OECD countries tend to differ in the way
waiting times are measured and utilised for benchmark-
ing or regulatory purposes. We identify the most common
measures and explain how these differ. We  then com-
pare waiting times across 12 OECD countries1 for common
surgical procedures (such as hip replacement and cataract).
We compare mean and median waiting times and their
1 Australia, Canada, Denmark, Ireland, Finland, the Netherlands, New
Zealand, Portugal, Slovenia, Spain, Sweden and the United Kingdom. None
of  the data contained in this study are available in [1].
 BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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istribution. We  illustrate time trends and relate sharp
eductions in waiting times to speciﬁc policy initiatives.
omparative information can feed into policy discussion
nd contribute to assessment of the waiting time phe-
omenon in each country. The analysis on time trends
erves to identify countries that have successfully and sig-
iﬁcantly reduced waiting times.
The analysis is part of the Second OECD Waiting Time
roject in 2011–2012 whose objectives were to compare
olicies across countries [1] and collect comparative wait-
ng times ﬁgures for speciﬁc procedures, which is the focus
f this study.2 The analysis relies on measures of waiting
imes from large administrative datasets for speciﬁc surgi-
al procedures.
Existing evidence on comparative waiting times is very
imited. Siciliani and Hurst [2] provide similar data for 2000.
hese are now out of date and refer to only one of the three
easures employed in this study (the inpatient waiting
ime of patient treated) for one point in time. Our study
pdates such data, employs additional common measures
the waiting time of patients on the list, and the waiting
ime from referral to treatment), explores the distribution
f waiting times and provides time trends covering a 10-
ear period.
There is limited evidence on waiting times from survey
ata especially from Commonwealth countries [4]. How-
ver, these are aggregated for any elective procedure and
ased on small samples. Evidence on waiting times con-
tructed from administrative data is based on large samples
often including the whole population who received treat-
ent), uses objective measures of waiting times and suffer
ess from aggregation bias (since it focuses on speciﬁc pro-
edures).
Recent work by the Swedish Association of Local
uthorities and Regions (SALAR) [5] compares Sweden
ith other countries. The same data have been used by
iberg et al. in an international comparison of waiting
imes in health care [6]. The latter describes how coun-
ries measure waiting times and assesses whether waiting
imes can be compared internationally. An initial attempt
o compare waiting times across countries is conducted for
ip replacement, cataract surgery and elective surgery in
009. The authors suggest that it is “difﬁcult and challeng-
ng to make meaningful comparisons of ofﬁcially published
aiting times in the 15 countries studies due to the many
ethodological differences in measuring. . .”.
Our study makes a ﬁrst important step in collecting
omparable waiting times data across OECD countries. Like
iberg et al. [6], we identiﬁed the most common deﬁni-
ions of waiting times. Through the Second OECD Waiting
ime Project we collected comparable waiting times for
ine surgical procedures over a 10-year period (and update
gures reported in [2]). As a result of our successful pilot,
 selection of waiting times variables were included in
he OECD Health Data base (2013). Our work makes two
ontributions to current knowledge. First, it contributes to
dvancing the comparability of waiting times data across
2 A summary of the First OECD Waiting Time Project is contained in
iciliani and Hurst [2], [3]. 118 (2014) 292–303 293
OECD countries. Second, the described time trends give an
opportunity to discuss major policy initiatives which con-
tributed to signiﬁcant reductions in waiting times.
2. Material and methods
The measurement of waiting times varies across coun-
tries. Common measures from administrative datasets are
the “inpatient waiting time” (from specialist addition to the
list to treatment) and the “referral-to-treatment waiting
time” (from GP/family doctor referral to treatment). Com-
mon  ﬁgures include the mean waiting time, the waiting
time at different percentiles of the distribution (e.g. the
median, or 90th percentile), and the number of patients
waiting more than a threshold (e.g. six months).
Waiting times are reported by procedure (e.g. hip
and knee replacement, cataract surgery) or by speciality
(e.g. ophthalmology, orthopaedics). They refer mainly to
two distributions: (i) the distribution of waiting times of
patients treated in a given period (e.g. a ﬁnancial year) and
(ii) the distribution of waiting times of the patients on the
list at a point in time (a census date).
2.1. Methods
The data were collected as part of the Second OECD
Waiting Time Project in 2011–2012. The data questionnaire
was sent to OECD data correspondents based primarily
in Ministries of Health and corresponding information
centres and statistical institutes (Table 1). In most cases
the data are from patient-level hospital administrative
databases. In some occasions they were ﬁrst reported at
hospital or regional level and then aggregated to national
level. The deﬁnitions employed build on those reported
by [2] under the First OECD Waiting Times project (that
collected only measure 1 below for one year following an
expert group meeting). The data collected under the Sec-
ond OECD Waiting Times project were presented at the
OECD Health Data Correspondents meeting held in Paris
in October 2012. As a result, a selection of waiting times
variables (measures 1 and 3 below) were subsequently
included in the OECD Health Data Base (2013) as part of
the regular data collection. Most countries report waiting
times for the vast majority of patients’ population and are
therefore highly representative. Most data collections are
available for a number of years and used for policy and
monitoring purposes. They are generally considered reli-
able and comparable within each country. Reliability has
improved quickly with time (see [1] for more details).
2.2. Deﬁnitions
Waiting times were collected for the following com-
mon  elective (non-emergency) surgical procedures: hip
replacement, knee replacement, cataract surgery, vaginal
hysterectomy, prostatectomy, cholecystectomy, inguinal
and femoral hernia, percutaneous transluminal coronary
angioplasty (PTCA) and coronary bypass. To classify surgi-
cal procedures, we  used ICD-9-CM codes as a reference (see
online Appendix). Data were collected from 1999 to 2011.
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Table 1
Sources of data and data coverage.
Country Institution reporting
data
Source of data Data coverage
Australia Australian Institute of
Health and Welfare
(AIHW)
2012: Australian Hospital Statistics 2011–2012: elective
surgery waiting times. Health Services Series n. 46. cat. no. HSE
127. Canberra: AIHW (Table 3.4 p. 18). 2002–2011: Australian
Institute of Health and Welfare 2012. Australian Hospital
Statistics 2010–2011. Health Services series no. 43. cat. no. HSE
117. Canberra: AIHW (Table 10.21 p. 288). Reference period:
1st July–30th June.Public hospital information sourced from
the National Elective Surgery Waiting Times Data Collection
(NESWTDC) and the linked data sourced from National
Hospital Morbidity Database (NHMD).
Includes all (publicly and
privately-funded) patients in
public hospitals.
Canada Canadian Institute for
Health Information
(CIHI)
Provincial wait-time registry representatives from each
province submit provincial summary level wait time data and
volumes of procedures to CIHI annually. Data are from
provincial registries or chart audits. Some provinces such as
Prince Edward Island and Newfoundland and Labrador do not
have registries. Data are published in an annual CIHI wait
times report. Provinces began submitting data according to a
standard deﬁnition in 2008.
Reference period: 1st April–30 September of each year or
nearest six month proxy.
Includes most provincial
institutions or outpatient
clinics where procedures are
performed. Wait times
measured from ‘the booking
date of surgery to date of
procedure.’ The booking date
will be after assessed by a
specialist but may have a time
lapse between this
appointment (or decision to
treat) and the booking date.
Denmark Ministry of Health and
National Board of
Health
Hospitals report data to the National Patient Register of the
Board of Health.
Includes all publicly-funded
patients in public hospitals,
private hospitals and clinics.
Finland National Institute for
Health and Welfare
(THL)
Care Register. From 2005 new legislation states the maximum
waiting times for health care services. Regions (central
hospital districts) exceeding maximum waiting times are
monitored by the National Supervisory Authority for Welfare
and Health (VALVIRA).
Includes all publicly-funded
patients.
Ireland National Treatment
Purchase Fund (NTPF)
Patient Treatment Register.Reference year is mid-year (end of
June).
Public hospitals with waiting
lists.
Netherlands National Health
Authority (NZa)
Hospitals are required to report data on waiting times on their
websites each month (self-reported prospective waiting times,
i.e.  how long a patient can expect to wait). Mediquest gathers
all  data from the websites of individual hospitals.
All hospitals and private clinics
performing care that is covered
by basic health insurance
(publicly funded patients).
New  Zealand National Health Board,
Ministry of Health
Public hospitals are required to provide data to the National
Booking Reporting System (NBRS), which is used by District
Health Boards and the Ministry of Health to monitor waiting
time for elective services. Data for waiting times of patients on
the list is as at December in each given year.
Public hospitals.
Portugal SIGLIC: the supporting
information system for
SIGIC
Integrated Management System of the Waiting List for Surgery
(SIGIC). Data are from the hospital operational systems
integrated in the central database of SIGLIC. The SIGLIC collects
information from different sources including hospitals,
regional health administrations, patients and ACSS
(Administrative Central Agency of Portugal’s National Health
Service).
All relevant providers–public
and private–in the ﬁve health
regions of continental Portugal.
Spain  Ministry of Health,
Social Services and
Equity
National Health System Information System on Waiting Lists. National Health System
network of hospitals (publicly
funded patients).
Sweden Swedish Association of
Local Authorities and
Regions (SALAR)
National waiting time database. The exact waiting times for any
patient is not known, hence
only an estimated number for
the median is provided.
UK–England The Health and Care
Information Centre
Hospital Episodes Statistics (HES). NHS providers submit data
to  the Secondary Uses Service (SUS) data warehouse. HES
extracts are taken from SUS on a monthly basis. HES includes
all admissions to NHS hospitals, all NHS outpatient
appointments and A&E attendances.
Includes NHS-funded patients
treated in NHS trusts and
independent providers.
UK–Scotland NHS National Services
Scotland
Information Services Division. General/Acute.
Inpatient and Day Case—SMR01 data. SMR01 is an
episode-based patient record relating to all inpatients and day
cases discharged from non-obstetric and non-psychiatric
specialties.
Publicly-funded patients.
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or a subset of measures data are available also for 2012
as part of the OECD Health Data collection, 2013).
Our questionnaire asked countries to provide waiting
imes according to four different deﬁnitions:
1. Inpatient waiting times (from specialist addition to
he list) of patients treated in a given year (publicly funded
atients).
This deﬁnition does not include ‘the time elapsed from
he date of referral of the general practitioner to the date
f specialist assessment’ (in some countries referred to as
outpatient waiting time’). Inpatient waiting times were
ollected for all ‘publicly-funded patients’ that received
reatment either by publicly or privately (non-proﬁt and
or-proﬁt) owned providers. We  do not focus on privately-
unded patients since waiting time data for these patients
re generally not collected on a routine basis.
2. Referral-to-treatment waiting times (from family doc-
or referral) of patients treated in a given year (publicly
unded patients).
Referral-to-treatment waiting times refer to “the time
lapsed from the family doctor (General practitioner) refer-
al to the date patients added to the non-emergency
elective) surgery waiting list were admitted to an inpatient
r day-case surgical unit for the procedure”. Therefore, it
ncludes also the time elapsed from the family doctor refer-
al to the specialist visit.
3. Inpatient waiting times (from specialist addition to
he list) of patients on the list at a census date (publicly
unded patients).
This measure is analogous to Measure 1 but refers to
he patients on the list at a given census date (as opposed to
atients treated in a given year). Inpatient waiting times on
he list includes “the time elapsed for a patient on the non-
mergency (elective) surgery waiting list from the date
hey were added to the waiting list for the procedure (fol-
owing specialist assessment) to a designated census date”.
4. Referral-to-treatment waiting time (from family doc-
or referral to treatment) of patients on the list at a census
ate (publicly funded patients).
This measure is analogous to Measure 3 but refers to the
otal waiting time of patients (starting from GP/family doc-
or referral) on the list at a given census date (as opposed
o the patients treated in a given year).
The distribution of waiting time of patients treated
easures the full duration of the patient’s waiting time
xperience (from entering to exiting the list). The distri-
ution of the waiting times of patients on the list is instead
incomplete”, since the patient’s wait has yet to come to
n end. The waiting time of patients treated has the advan-
age of capturing the full duration of a patient’s journey,
ut is retrospective in nature. The main advantage of the
aiting time of patients on the list is that it captures the
xperience of the patients who are still waiting at a point in
ime [7].
For each measure, we collected mean and median
aiting time, and the proportion of patients waiting 0–3
onths, 4–6 months, 7–9 months, 10–12 months and over
2 months. The latter focus on patients who are most dis-
dvantaged, i.e. those with the longest wait (although if
rioritisation works well, these are likely to be patients
ith lowest severity). 118 (2014) 292–303 295
Eight countries provided inpatient waiting times data
for patients treated; six for inpatient on the list. One coun-
try (Denmark) provided data on referral to treatment for
patients treated (measure 2). No country could provide
measure 4. Note that referral-to-treatment waiting times
are collected in England but not by surgical procedure (only
by speciality or for all specialities; see [1], chapter 2).
3. Results
3.1. The mean waiting time can be substantially higher
than the median
Table 2 provides mean and median waiting times, in
days, in 2011 and 2012 according to our three deﬁni-
tions. The results described refer to 2011 (unless explicitly
stated).
The mean waiting time is systematically higher than
the median conﬁrming the skewed distribution of waiting
times. The difference can be quantitatively large. In England
and Scotland, the mean was  8–34% higher. Among coun-
tries that report both mean and median waiting time for
patients treated in 2011 (Finland, New Zealand, Portugal,
England and Scotland) the correlation for a given procedure
is very high (above 0.9 for seven out of nine procedures).
3.2. Waiting times are low in the Netherlands and
Denmark
Among countries reporting inpatient waiting times of
patients treated (upper part of Table 2), the Netherlands
exhibits the lowest: mean waiting times are below one
month and a half. Denmark also exhibits short waiting
times, despite their measure including the additional wait
from GP referral to specialist appointment.
3.3. Waiting times of patients treated differ
systematically from those of patients on the list
Three countries (New Zealand, Portugal and Spain)
report inpatient waiting times both for patients treated
and on the list. The two  measures generally provide dif-
ferent results and are therefore not comparable. For New
Zealand, the mean/median waiting time of patients treated
is generally higher than for those on the list (except for
coronary bypass in 2011 and 2012 and PTCA in 2012). This
is also the case for Spain. For Portugal this holds only for
one procedure in 2011 and 2012: knee replacement. The
opposite holds for seven procedures in 2011 and ﬁve pro-
cedures in 2012 with mean and median waiting time being
lower for patients treated than on the list. The distribution
of patients on the list over-samples long-waiting patients.
Since Portugal has a longer tail of patients with long wait-
ing times, this may  explain the different results for this
country.
In Sweden waiting times are provided for only four
procedures. They appear generally low compared to other
countries. Slovenia reports relatively long waiting times
compared to any other country, in particular for hip and
knee replacement, and PTCA.
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Table 2
Median (mean) waiting times in days for common surgical procedures.
Hip
replacement
Knee
replacement
Cataract Hysterectomy Prostatectomy Cholecystectomy Hernia CABG PTCA
Patients treated–Inpatient (time from specialist addition to list to treatment)
Australia 2011 108 173 90 49 47 54 57 17
2012  116 184 91 53 42 16
Canada 2011  89 107 49 7
2012  87 106 46 8
Finland  2011 113
(127)
136
(149)
111
(114)
81
(94)
49
(68)
69
(90)
76
(96)
43
(58)
23
(34)
Netherlands 2011  (46) (44) (33) (35) (32) (35) (36) (27) (16)
2012  (42) (42) (35) (34) (31) (29) (16)
New  Zealand 2011 90
(104)
96
(112)
84
(94)
98
(109)
63
(86)
62
(86)
57
(82)
28
(37)
51
(66)
2012  99
(104)
111
(114)
88
(94)
90
(96)
66
(81)
27
(44)
38
(49)
Portugal 2011 87
(128)
195
(206)
49
(66)
57
(86)
62
(101)
80
(134)
82
(120)
2
(24)
2012  105
(140)
210
(211)
59
(83)
57
(85)
63
(106)
2
(34)
Spain 2011 (127) (89) (91) (89) (87)
2012 (161) (108) (97)
UK-England 2011 82
(90)
87
(97)
59
(66)
62
(70)
31
(41)
70
(81)
60
(71)
53
(63)
35
(40)
UK-Scotland 2011 75
(90)
80
(94)
62
(70)
48
(53)
51
(55)
61
(77)
63
(82)
35
(47)
29
(33)
Patients treated–Referral to treatment (time from family doctor referral to treatment)
Denmark 2011 39
(51)
46
(59)
70
(99)
35
(49)
36
(56)
38
(46)
45
(56)
13
(19)
Patients on the list–Inpatient
Ireland 2011 103
(130)
119
(153)
118
(144)
96
(131)
81
(127)
93
(132)
98
(128)
77
(102)
54
(78)
2012  83
(100)
100
(113)
133
(146)
118
(126)
90
(118)
107
(133)
64
(97)
New Zealand 2011 60
(78)
65
(84)
51
(63)
65
(73)
51
(66)
58
(75)
54
(69)
46
(60)
38
(51)
2012  63
(72)
68
(74)
53
(62)
55
(69)
49
(63)
35
(45)
39
(46)
Portugal 2011 137
(191)
164
(201)
67
(100)
67
(98)
110
(189)
117
(178)
95
(147)
88
(114)
2012  124
(178)
146
(192)
77
(108)
67
(101)
97
(192)
75
(145)
Spain 2011 (93) (71) (74) (74) (71)
2012 112 (86) (85)
Sweden 2011 43 45 40 25
Slovenia 2011  340
(354)
495
(512)
58
(63)
90
(122)
90
(132)
240
(275)
2012 341
(345)
380
(504)
92
(108)
64
(81)
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.4. There is evidence of prioritization across treatments
There is a clear evidence of prioritization across differ-
nt procedures. Waiting times for more urgent procedures,
uch as coronary bypass and PTCA, are generally lowest.
hey are higher for less urgent procedures such as hip
eplacement. This is unsurprising; doctors are trained to
rioritize patients on the waiting list. There is an increasing
olicy focus on developing guidelines to improve prioriti-
ation of patients on the list across the OECD countries,
ut in particular New Zealand, Canada, Norway and other
ordic countries ([1], chapter 3).
.5. Waiting times are not always highly correlated
cross procedures
We  may  ponder the extent to which a country will have
ong waiting times for more than one particular procedure,
s a result for example, of a tighter capacity constraint
cross the whole system.
In some instances such correlations are high but sensi-
ive to the measure and sample of countries considered.
e  computed the correlation across eight procedures
excluding PTCA) for six countries that reported mean wait-
ng time for patients treated (Finland, the Netherlands,
ew Zealand, Portugal, Scotland and England) in 2011.
xcluding coronary bypass and cataract surgery, the corre-
ations among the remaining six procedures were relatively
igh—above 0.65. Cataract surgery had a correlation that
anged between 0.44 (with cholecystectomy) and 0.82
with hysterectomy). Coronary bypass generally exhibits
ow correlation with the other procedures and a wide
ange between 0.36 (with prostatectomy) and 0.50 (with
ataract surgery). This is due to England and Scotland hav-
ng relatively longer waiting times for coronary bypass
ompared to the other countries, while performing well on
he other procedures. The results were similar when Spain
as included in the sample (with only ﬁve procedures).
hen using the median waiting time of patients treated
orrelations were generally lower. When considering the
atients on the list, a similar picture generally emerged.
.6. Distribution of waiting times
We  can gain some insights by looking at the distribution
f waiting times, which also allows a focus on long wait-
rs. We  provide histograms for the proportion of patients
aiting 3 months or less, between 4 and 6 months, between
 and 9 months, between 10 and 12 months, and over 12
onths. We  focus on hip replacement and cataract surgery.
Fig. 1a shows the distribution of waiting times of
atients treated for hip replacement. The distribution is
kewed; most patients receive treatment quickly with
ore than 50% being treated within 3 months in the UK,
ortugal and New Zealand (but not in Finland). Many of
he remaining patients are treated within 6 months (except
or Portugal). There is a tail of patients waiting more than months: around 6–7% in the UK, 15–18% in New Zealand
nd Finland and 28% in Portugal.
The distribution can differ signiﬁcantly. For example,
ortugal and New Zealand both have a median waiting time 118 (2014) 292–303 297
for hip replacement of about 3 months. However, the pro-
portion waiting over 6 months is 15% in New Zealand and
28% in Portugal leading to a larger mean waiting time in
Portugal (128 days) than in New Zealand (104 days). This
shows how synthetic measures can hide signiﬁcant varia-
tions in the distribution.
We can also compare the distribution of patients treated
(Fig. 1a) versus the distribution of patients on the list
(Fig. 1b). The comparison of Fig. 1a with Fig. 1b for hip
replacement shows how these distributions differ. In New
Zealand, the proportion of patients treated waiting more
than 6 months is about 15% but the proportion of patients
on the list waiting more than 6 months is only 6%. This
is unsurprising as the distribution of patients on the list
suffers from ‘interruption’ bias (it measures an incom-
plete wait), which biases the measure downwards, and
reﬂects ‘oversampling’ of long-wait patients, which biases
the measure upwards. Although these biases go in oppo-
site directions, there is no reason why  these should be
the same. In some cases the ﬁgures between the two dis-
tributions may  not be too dissimilar. For example, for
Portugal the proportion of patients waiting more than 6
(12) months is in the range 27–28% (11–12%) under both
distributions.
As an additional example, consider cataract surgery in
Fig. 2a and b. The proportion of patients treated waiting
more than 6 months is 8% in New Zealand and it is higher
than the proportion of patients on the list, which is around
3%. In Portugal the opposite holds.
Such distributions show different degrees of disper-
sions in waiting times across countries. These can be the
result of a range of factors including prioritisation policies
(which reduce waiting times for high-severity patients and
increase them for low-severity patients) but also variations
in demand (age compositions within or across countries)
and in supply within a country (differences across hospi-
tals).
3.7. Time trends
Time trends in Fig. 3 show that waiting times have been
relatively stable in most countries and across procedures.
There are, however, several cases where waiting times have
reduced. In particular, the United Kingdom and Finland
have experienced large reductions in waiting times from a
relatively high level in early 2000s. There are also declining
trends for the Netherlands, Denmark and Portugal although
this trend has reversed in recent years in Portugal.
In Finland waiting times are generally stable or
increasing up to 2002 or 2003 and then character-
ized by a sharp substantial reduction: about 43–48% for
hip and knee replacement, 30–51% for prostatectomy,
hysterectomy, cholecystectomy and hernia, 55% for
cataract and 24% for bypass. In the United Kingdom
waiting times have been gradually falling starting from
2001/2002. In England waiting times more than halved
for several procedures. In Scotland reductions in waiting
times were of the order 25–40%. In 1999 waiting times
were generally longer in England than in Scotland. By 2011
they were comparable. Waiting times have therefore fallen
more rapidly in England than in Scotland. The UK has also
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Fig. 1. (a) Hip replacement; patients treated (2
experienced moderate increases in recent years except for
hysterectomy.
In New Zealand waiting times of patients treated
have been fairly stable over the period 2003–2011. Hys-
terectomy, cholecystectomy and hernia experienced some
increases, and coronary bypass some reductions in recent
years. The dynamics of waiting times for patients on the
list looks rather different. Over the same period, the wait-
ing time of the patients on the list has more than halved for
most procedures. One explanation for different trends is
that the latter also includes patients who ultimately do not
receive treatment. As time passes, providers may  become
more active at ‘validating’ the waiting list and/or regularly
checking that patients on the list still require treatment,
i.e. quickly removing them when it becomes apparent
that treatment is no longer necessary (see [12] for more
details).
In the Netherlands, waiting times have reduced over
the period 2006–2011 for hip and knee replacement,
cataract and to a less extent for coronary bypass while theygal Irela nd
) Hip replacement; patients on the list (2011).
were stable for the remaining procedures, and increased
slightly for cholecystectomy and hernia. Waiting times are
low compared to other countries and have been low for
at least ﬁve years. Compared to ﬁgures for 2000 provided
by [3], waiting times have signiﬁcantly reduced and more
than halved for several procedures.
In Denmark,  we observe reductions for hip and knee
replacement (by more than 30%), prostatectomy (20%) and
modest reductions for cholecystectomy over the period
2005–2011, increased for cataract (more than 50%), while
waiting times are relatively constant for the other pro-
cedures. We  observe reductions in waiting times across
most procedures for Portugal although these started to
reverse in 2011 with the exception of hysterectomy. The
recent increases in waiting times are most pronounced for
patients treated.Ireland has witnessed considerable reductions in
waiting times of patients on the list–particularly over
2007–2008—for hip and knee replacement, prostatectomy
and cholecystectomy. Similar to Portugal and New Zealand,
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hese sharp decreases can in part be attributed to some
alidation of the waiting list [17]. In contrast, there was
n increase in waiting times for cataract surgery during
010–2012 and hysterectomy during 2010–2011. There
as a particularly sharp increase for coronary bypass
urgery from 2009 to 2010 but this subsequently decreased
n 2011 and rose again in 2012.
Waiting times in Spain have been either stable or
educed to some extent in recent years (2003–2011) but
ave increased in 2012 for cataract, prostatectomy and
ip replacement. In Australia,  median waiting times for
atients treated have generally gradually increased during
002–2012, sometimes signiﬁcantly (knee replacement,
ysterectomy, cholecystectomy by 32–47%, prostatectomy
nd hernia by 41–58%) but have been stable for cataract
nd coronary bypass. In Canada, data are available only
or 2008–2011 for selected procedures. Median waiting
imes for hip and knee replacement have been moderately) Cataract surgery; patients on the list (2011).
increasing (by less than 10% over ﬁve years), and relatively
stable for cataract. In Sweden, data are available only for
2010 and 2011. These suggest reductions in median waiting
time of patients on the list for hip and knee replacement,
and cataract surgery by 11–14%.
4. Discussion
4.1. Reasons for the reduction in waiting times
OECD countries pursued a range of policies in order to
achieve reductions in waiting times. Finland introduced
a National Health Care Guarantee into law in 2005 [8].
For elective treatment the guarantee was  three months
(with few exceptions). Hospitals that failed to comply were
scrutinized by the Supervisory Agency (Valvira) and were
subject to a threat of ﬁnes. The reductions in waiting times
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were associated with an increase in health expenditure for
municipalities in the ﬁrst years of the guarantee [8].
The considerable reduction in waiting times in the
United Kingdom can be explained by (1) a sustained growth
in health expenditure in the last decade, and (2) the use of
waiting-time targets. In England, heavy sanctions for hospi-
tals not respecting the targets were introduced from 2000,
a policy known as “targets and terror” [9,10]: senior health
administrators were at risk of losing their jobs if targets
were not met. This may  explain why reductions in waiting
times in England were larger than for Scotland. Although in
Scotland hospitals were not subject to economic penalties,
regional health boards from 2003 to 2004 were monitored
monthly on the achievement of waiting time targets. Indi-
vidual breaches had to be reported to the Scottish Executive
and were investigated [11].
In the Netherlands, the reductions in waiting times
between 2000 and 2006 were achieved following a radical
change in the hospital ﬁnancing system which switched
from ﬁxed budgets to activity-based funding [13,14].
Additional reductions in recent years can be attributedctomy; (d) hernia; and (e) coronary bypass
to a reform of specialist payments leading to a change
from lump-sum payments to activity-based payments in
2008, and an expansion of price competition (as part of a
broader managed competition reform) since 2005 [13]. As
a result of these reforms, waiting times are not a signiﬁ-
cant health policy issue as they were in the 1990s. Concerns
have however, been raised about the rapid growth in health
expenditure that activity-based ﬁnancing has promoted.
A key policy in Denmark has been “free choice” of hos-
pital provider for patients. The scheme implies that if the
hospital can foresee that the maximum time cannot be ful-
ﬁlled, then the patient can choose another public or private
hospital, either within or outside Denmark [15]. In 2002
the maximum waiting time guarantee was  two  months
(and replaced a former guarantee of three months). The
guarantee was  further reduced to four weeks in 2007 (inde-
pendent of disease type and severity). “Free choice” was
suspended in 2008–2009 due to a hospital personnel strike
[15].
In Portugal, reductions in waiting times were obtained
through a series of policy initiatives, which included a new
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Fig. 3. (Continued).
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integrated information system combined with a voucher
system for patients reaching 75% of max  waiting time guar-
antee [16]. We  also noted sharp reductions for the patients
on the list between 2006 and 2007 which, similar to New
Zealand, were possibly obtained by more accurate valida-
tion of the list (also experienced in England in the 1980s,
[2]).
A number of initiatives have been introduced in Spain,
mainly targeting the supply side, including extending
working hours for health personnel, additional resources
and new ambulatory surgery centres [18].
4.2. Possible sources of errors
Like any international data collection using administra-
tive data, there may  be sources of errors. We  deﬁne waiting
times at surgical procedure level using ICD-9-CM. The
approach is analogous to other international data collec-
tions measuring total inpatient surgical procedures (OECD
Health Statistics). Although some countries use alternative
methods (such as ICD-10) these are unlikely to create seri-
ous biases. We  did not attempt to collect data at speciality
level (ophthalmology, orthopaedics, etc) since deﬁnitions
of specialities may  differ signiﬁcantly.
For inpatient waiting times, (small) differences can arise
within and across countries regarding when the patient is
added to the list following specialist assessment (e.g. there
may  be a delay between decision to treat and formally being
added to the list). This is not the case for the time the wait
ends, which is more unambiguously deﬁned.
Many countries have a mix  of both public and private
providers. Public hospitals tend to treat publicly-funded
patients and to a minor extent private patients (if dual prac-
tice is allowed). Private providers differ in the extent to
which they treat publicly-funded patients. Our focus is on
publicly-funded patients and this could be accommodated
in most countries.
When data are reported at hospital/regional level, care
has to be exerted when aggregating waiting times (e.g.
weighting by appropriate volumes).
5. Conclusion
5.1. Waiting times: what should policymakers measure?
Policymakers have at their disposal a range of measures
to collect waiting times. We  emphasize systematic differ-
ences between the distribution of waiting times of patients
treated versus the distribution of patients on the list. For
example, the mean waiting time of patients on the list is
generally higher than of patients treated although exam-
ples of the opposite exist (and similarly for other measures).
These differences naturally raise the question of what
policymakers should measure and under what circum-
stances. For regulatory and monitoring purposes, the
waiting time of patients on the list provides a more ‘up-
to-date’ ﬁgure of providers’ effort to keep waiting times
within stated targets and is preferred (the other measure
reﬂecting instead past efforts).
In terms of reporting to prospective patients (as part
of patient’s choice policies) and the general public, the 118 (2014) 292–303
waiting time for patients treated is preferred as patients
are interested in the full expected duration of the wait (the
other measure suffers from interruption bias). Since exist-
ing measures are from administrative data, the same data
sources can be employed to generate both distributions at
low additional costs.
In terms of statistics employed, for regulatory pur-
poses both the median and the proportion of long-waiting
patients should be recorded. The latter ensures that no sig-
niﬁcant portion of patients have unreasonable waits. The
median is more representative and at the same time reveals
whether a low proportion of long waiters is obtained by let-
ting patients with middle or high severity (who wait less)
wait for a relatively longer time. For public reporting, the
proportion of long waiters and the mean is more easily
understood by patients and the general public.
The analysis suggests that most countries measure the
‘inpatient’ wait with few countries moving towards the
wait from GP referral to treatment. In the short run, coun-
tries can focus on inpatient waiting times, which capture
the bulk of the wait. Measuring the referral-to-treatment
waiting times raises technical issues. For example, when
the patient starts waiting, following a GP visit, she (nor her
GP) may  not know whether she will be admitted only for
a specialist visit or for an inpatient treatment (following
a specialist visit). Therefore, the waiting time of patients
on the list may  include patients belonging to both groups,
while the wait of the patients treated can be disaggregated
in two groups (as in England). In the long run, it seems
desirable to capture the full patient’s journey; short inpa-
tient waiting times could be obtained at the cost of long
waits for a specialist visit.
In terms of international reporting, the inpatient wait-
ing time of patients treated seems the most viable option
in the current state of affairs. It is the most commonly
available and captures most of patient’s wait experience.
In the future, other countries may  become interested in
reporting waiting times. Ultimately, waiting times mea-
sure the difference between two  events and are compatible
with current DRG-type administrative databases. Given the
current economic climate, ageing population and techno-
logical progress, demand for health care may  increase at a
faster rate than supply, even in countries historically char-
acterized by low waiting times.
5.2. Successful policies to reduce waiting times
The analysis provides new comparative evidence on
waiting times. Waiting times appear to be low in the
Netherlands and Denmark. The United Kingdom, Finland
and the Netherlands have witnessed large reductions in
waiting times in the last decade.
A common policy is the introduction of maximum wait-
ing time guarantees, where patients should not wait more
than a pre-determined time. Such guarantees are increas-
ingly linked to clear economic incentives and combined
with increased resources. However, economic incentives
can differ signiﬁcantly across countries along with the
implementation of such guarantees.
One option is to use maximum waiting-times guar-
antees as targets (as in England and Finland). Providers
th Policy
n
t
a
a
i
(
i
p
ﬁ
p
a
b
w
i
t
p
w
f
s
a
w
s
t
e
i
U
t
m
c
a
c
h
t
f
e
a
u
a
w
e
ﬁ
w
t
p
w
c
l
p
f
z
m
w
C
i
[
[
[
[
[
[
[
[L. Siciliani et al. / Heal
ot respecting the targets were penalised with sanc-
ions (either ﬁnancially or non-ﬁnancially). Combined with
dditional resources (necessary to increase supply), this
pproach has proven successful.
A second possibility is to combine maximum wait-
ng times with patients’ choice and competition policies
Denmark, the Netherlands and Portugal). Patients wait-
ng above the target are entitled to treatment by another
ublic or private provider. The originating provider may  be
nancially responsible for some expenses incurred. These
olicies also are accompanied with additional resources,
nd have been successful in reducing waiting times.
A key insight is that supply policies only are unlikely to
e successful in reducing waiting times. However, they can
ork if demand is kept under control. The latter can implic-
tly be obtained with the introduction of maximum waiting
ime guarantees. These will ensure that the higher sup-
ly is not offset by equivalent increases in demand leaving
aiting times unchanged.
The Dutch experience however, highlights that success-
ul policies to reduce waiting times can be associated with
igniﬁcant costs. Health expenditure can increase sharply
nd policymakers need to trade off the beneﬁts from lower
aiting times and higher patients’ care with its costs.
We may  wonder what triggered countries to introduce
uccessful policies. For Finland and the United Kingdom,
he answer probably lies in the very long waiting times
xperienced in the late 1990s (more than double those
n other European countries). Health expenditure in the
K had historically been below European average. Waiting
imes have now converged to the average. The imple-
entation of targets involves a top-down approach. Other
ountries (e.g. Denmark) may  prefer a more consensual
pproach. Policies based on patients’ choice appear less
ontroversial and may  be preferred.
The negative trend in waiting times seems to have
alted and even reversed in recent years, most likely due
o the economic recession. These increases are evident
or Portugal in 2011 and 2012 while the UK has experi-
nced some increases albeit to a lesser extent. There were
lso increases in Spain and Finland. Governments may  be
nable to increase supply in the near future (or not as much
s in early 2000).
It is worth considering whether recent increases in
aiting times were inevitable. With limited resources,
nforcement of maximum waiting time guarantees is dif-
cult. Without additional resources, providers can keep
aiting times down only by controlling demand or fur-
her increasing productivity. Both strategies are costly for
roviders. Although governments can ask providers to
ork more efﬁciently, this may  be counter-productive and
ome at the cost of lower quality, staff dissatisfaction and
ow morale. Setting realistic maximum waiting times com-
atible with available budgets will be critical.
With limited resources, policymakers may  need to shift
ocus from reduced waiting times to improved prioriti-
ation, ensuring patients with higher severity are treated
ore quickly, and long waits are concentrated among those
ho can afford the health costs of waiting. Countries like
anada and New Zealand have experimented with formal-
zed prioritization tools (based on severity scoring systems)
[ 118 (2014) 292–303 303
although these are generally available only for speciﬁc
treatments, and can be expensive to develop. Although
doctors already prioritize patients, the development of
guidelines which encourage prioritization may  be beneﬁ-
cial.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.healthpol.2014.08.011.
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